Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effect of NovoMix 30, Levemir or NovoRapid (Alone or in Combination) in Subjects With Type 2 Diabetes Previously Treated With Other Anti-Diabetic Medication. A 24-Week, International, Prospective, Multi-Centre, Open-Labelled, Non-Interventional Study.

Next Previous
Search
Trial Profile

The Effect of NovoMix 30, Levemir or NovoRapid (Alone or in Combination) in Subjects With Type 2 Diabetes Previously Treated With Other Anti-Diabetic Medication. A 24-Week, International, Prospective, Multi-Centre, Open-Labelled, Non-Interventional Study.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin aspart (Primary) ; Insulin detemir (Primary) ; Insulin aspart/insulin protamine aspart
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms A1chieve
  • Sponsors Novo Nordisk

    • Most Recent Events

    • 20 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
    • 20 Apr 2011 Actual end date reported as Dec 2010 by ClinicalTrials.gov.
    • 19 Jul 2010 The results of this study will be available in 2011, according to a Novo Nordisk media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top